Optimization of Important Early ADME(T) Parameters of NADPH Oxidase-4 Inhibitor Molecules

被引:3
|
作者
Borbely, Gabor [1 ,2 ]
Huszar, Monika [1 ]
Varga, Attila [1 ,2 ]
Futosi, Krisztina [4 ]
Mocsai, Attila [4 ]
Orfi, Laszlo [2 ,3 ,5 ]
Idei, Miklos [1 ]
Mandl, Jozsef [6 ]
Keri, Gyoergy [1 ,2 ,3 ]
Vantus, Tibor [1 ]
机构
[1] Semmelweis Univ, Dept Med Chem, Pathobiochem Res Grp, Hungarian Acad Sci, Budapest, Hungary
[2] Semmelweis Univ, Rat Drug Design Lab CRC, Budapest, Hungary
[3] Vichem Chem Res Ltd, Budapest, Hungary
[4] Semmelweis Univ, Fac Med, Dept Physiol, Budapest, Hungary
[5] Semmelweis Univ, Dept Pharmaceut Chem, Budapest, Hungary
[6] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary
关键词
ADME(T); characterization; compounds; disease; inhibitor; NADPH oxidase 4; relationship; ARTIFICIAL MEMBRANE; LIPOPHILICITY; PERMEABILITY;
D O I
10.2174/157340612800493674
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Through their reactive oxygen species (ROS) producing function, NADPH oxidase (NOX) enzymes have been linked to several oxidative stress related diseases. In our recently published paper [1] we have already shown the NOX4 inhibitory effect of diverse, molecule sub-libraries and their biological importance. We also presented our work connected to potential anti-tumour molecules and the relationship between their biological activity and physico-chemical properties [2]. As an extension of these studies further physico-chemical and biological investigation has been carried out on a molecule group included NOX4 inhibitory chromanone compounds. Here we describe the optimization of early ADME(T) parameters determining lipophilicity, phospholipophilicity and permeability linked to structure-activity relationship. We prove that optimal lipo-and phospholipophilicty can be also determined in case of NOX4 inhibitors and a comparison will be made between the chemically similar isochromanone and chromanone molecular libraries. It will be also shown how to predict the effect of different substituents on permeability, lipo- and phospholipophilicity and also the biological differences between anti-tumour molecules and NOX4 inhibitors according to their penetration ability.
引用
收藏
页码:174 / 181
页数:8
相关论文
共 50 条
  • [41] Glaucoma causes redox imbalance in the primary visual cortex by modulating NADPH oxidase-4, iNOS, and Nrf2 pathway in a rat experimental model
    Hvozda Arana, Ailen G.
    Lasagni Vitar, Romina M.
    Reides, Claudia G.
    Fabian Lerner, S.
    Ferreira, Sandra M.
    EXPERIMENTAL EYE RESEARCH, 2020, 200
  • [42] Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat
    Kono, H
    Rusyn, I
    Uesugi, T
    Yamashina, S
    Connor, HD
    Dikalova, A
    Mason, RP
    Thurman, RG
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 280 (05): : G1005 - G1012
  • [43] Kupffer cell nadph oxidase plays an important role in early alcohol-induced liver injury in mice
    Kono, H
    Rusyn, I
    Bladford, BU
    Segel, B
    Holland, SM
    Thurman, RG
    HEPATOLOGY, 1999, 30 (04) : 336A - 336A
  • [44] NADPH oxidase-4, a novel pro-fibrogenic mediator, is upregulated in fibroblastic foci and in mesenchymal cells isolated from lungs of patients with idiopathic pulmonary fibrosis
    Hecker, L.
    Zhou, Y.
    Luckhardt, T.
    Ding, Q.
    Thannickal, V. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [45] NADPH oxidase-4 promotes adaptive cardiac remodelling in the chronically stressed heart by driving protein O-GlcNAcylation and enhancing cardiac fatty acid oxidation
    Nabeebaccus, A. A. Adam Abner
    Zoccarato, A.
    Hafstad, A. D.
    Santos, C. X. S.
    Aasum, E.
    Brewer, A. C.
    Zhang, M.
    West, J.
    Griffin, J.
    Eykyn, T.
    Mayr, M.
    Shah, A. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 6 - 7
  • [46] Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis
    Hakami, Nora Y.
    Dusting, Gregory J.
    Peshavariya, Hitesh M.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (10) : 1932 - 1944
  • [47] MD2 blockade prevents modified LDL-induced retinal injury in diabetes by suppressing NADPH oxidase-4 interaction with Toll-like receptor-4
    Huaicheng Chen
    Tao Yan
    Zongming Song
    Shilong Ying
    Beibei Wu
    Xin Ju
    Xi Yang
    Jia Qu
    Wencan Wu
    Zongduan Zhang
    Yi Wang
    Experimental & Molecular Medicine, 2021, 53 : 681 - 694
  • [48] MD2 blockade prevents modified LDL-induced retinal injury in diabetes by suppressing NADPH oxidase-4 interaction with Toll-like receptor-4
    Chen, Huaicheng
    Yan, Tao
    Song, Zongming
    Ying, Shilong
    Wu, Beibei
    Ju, Xin
    Yang, Xi
    Qu, Jia
    Wu, Wencan
    Zhang, Zongduan
    Wang, Yi
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2021, 53 (04): : 681 - 694
  • [49] NADPH Oxidase-4 (Nox4) Mediated Nitration of Striatal Axonal Neurofilaments and a Dysregulation in Redox Adaptation are Associated with Dopaminergic Denervation in the Aging HIV-1 Transgenic Rat
    Reid, William
    Shah, Swati
    Denaro, Frank
    Ibrahim, Wael G.
    Mason, Ronald P.
    Kumar, Ashutosh
    Maric, Dragan
    Hammoud, Dima A.
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 112 : 56 - 56
  • [50] A novel NADPH oxidase inhibitor targeting Nox4 in TGFβ-induced lens epithelial to mesenchymal transition
    Das, Shannon
    Wikstrom, Per
    Walum, Erik
    Lovicu, Frank J.
    EXPERIMENTAL EYE RESEARCH, 2019, 185